Covington Capital Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
Other funds holding BSX
BG
Covington Capital Management's BSX Position: Q3 2022 in Review
Covington Capital Management increased its Boston Scientific (BSX) stake by 3.9% in Q3 2022, buying an estimated $2.29K and bringing the position to 1,525 shares worth $59K. The position accounts for ﹤0.01% of the portfolio, ranked #539.
Covington Capital Management first reported a position in BSX in Q3 2017 and has held it in 21 quarters since. The position peaked at $110K in Q1 2019. 865 funds tracked by Wall St. Rank hold BSX as of Q3 2022.
- Covington Capital Management held 1,525 shares of Boston Scientific worth $59K as of Q3 2022.
- Covington Capital Management bought 57 Boston Scientific shares in Q3 2022, an estimated $2.29K.
- Boston Scientific made up ﹤0.01% of Covington Capital Management's portfolio in Q3 2022, its #539 holding.
- Covington Capital Management first reported a position in Boston Scientific in Q3 2017 and has held it in 21 quarters since.
- Covington Capital Management's Boston Scientific position peaked at $110K in Q1 2019.
- 865 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2022.
Based on Covington Capital Management's 13F filing for Q3 2022, filed 15 Nov 2022.